Private company
Lincoln Alternative Strategies LLC
Pooled investment fund that raised $18 million in 2024 (SEC Form D). Summary from the record
Last updated Oct 21, 2026.
Overview
Corporate structure
Lincoln Alternative Strategies LLC sits at the top of its group. 15 entities, 4 countries on record. Switch between the flow chart and the network, and select any entity to see its details.
- Lincoln Alternative Strategies LLC DE
- BioCardia, Inc. Stake · San Carlos, California, United States
- BioNano Genomics Stake · San Diego, California, United States
- Calidi Biotherapeutics, Inc. Stake · San Diego, California
- Cel-Sci (United States) Stake · Vienna
- Celularity Inc Stake · Florham Park, New Jersey
- GRI Bio, Inc. Stake · La Jolla, California
- Jaguar Health, Inc. Stake · San Francisco, California, United States
- Kitov Pharma Stake · תל אביב-יפו
- Longeveron Inc. Stake · Miami, Florida
- MELA Sciences Stake · Irvington
- Silexion Therapeutics Corp Stake · George Town, Cayman Islands
- Twin Vee PowerCats, Co. Stake · Ft. Pierce, Florida
- Vision Marine Technologies Inc. Stake · Boisbriand, Canada
- XORTX Therapeutics Inc. Stake · Calgary, Alberta, Canada
Built from major holders from Schedules 13D and 13G; stakes of 5% or more it reported on Schedules 13D and 13G (14 companies). Each entity in the chart links to its source.
Leadership
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Managing MemberStephen J Temes named Feb 25, 20252
Filings
1 filings to the SEC since October 2021: 1 private raises. The latest 1:
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Stakes it holds
Lincoln Alternative Strategies LLC has told the SEC it owns more than 5% of 14 companies, latest first (Schedules 13D and 13G).
- Twin Vee PowerCats, Co.SCHEDULE 13G Mar 25, 20263
- Celularity IncSCHEDULE 13G/A Aug 27, 2025 to Feb 11, 20264
- Calidi Biotherapeutics, Inc.SCHEDULE 13G/A Aug 27, 2025 to Feb 10, 20265
- GRI Bio, Inc.SCHEDULE 13G/A Dec 29, 2025 to Feb 10, 20266
- Jaguar Health, Inc.SCHEDULE 13G/A Aug 29, 2025 to Feb 10, 20267
- Longeveron Inc.SCHEDULE 13G/A Aug 27, 2025 to Feb 10, 20268
- Vision Marine Technologies Inc.SCHEDULE 13G/A Aug 27, 2025 to Feb 10, 20269
- XORTX Therapeutics Inc.SCHEDULE 13G Oct 27, 202510
- BioCardia, Inc.SCHEDULE 13G Sep 19, 202511
- BioNano GenomicsSCHEDULE 13G Sep 17, 202512
- Silexion Therapeutics CorpSCHEDULE 13G Sep 15, 202513
- Kitov PharmaSCHEDULE 13G Sep 9, 202514
- MELA SciencesSCHEDULE 13G Sep 4, 202515
- Cel-Sci (United States)SCHEDULE 13G Aug 29, 202516
Money raised
Private offerings the company reported to the SEC on Form D.
- Sep 1, 2024Raised $18 million in a private offering of equity Form D: $250 million offered in all Form D
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16